Darlix, A.
756  results:
Search for persons X
?
2

P11.21.A LONG-TERM SURVIVAL WITH IDH WILDTYPE GLIOBLASTOMA:..:

Weller, M ; Felsberg, J ; Gramatzki, D...
Neuro-Oncology.  25 (2023)  Supplement_2 - p. ii77-ii77 , 2023
 
?
3

P02.21.A A BIOBANK OF IDH1-MUTANT CELL LINES FOR STUDYING T..:

Garcia, L ; Pineau, D ; Hideg, S...
Neuro-Oncology.  25 (2023)  Supplement_2 - p. ii34-ii35 , 2023
 
?
4

P01.15.A Longitudinal assessment of neurocognition and qual..:

Darlix, A ; Fabbro, M ; Monnier, M...
Neuro-Oncology.  24 (2022)  Supplement_2 - p. ii27-ii27 , 2022
 
?
5

P11.19.B Bevacizumab in recurrent WHO grade 2-3 gliomas:

Annakib, S ; Rigau, V ; Darlix, A...
Neuro-Oncology.  24 (2022)  Supplement_2 - p. ii60-ii60 , 2022
 
?
7

KS02.4.A Olaparib in Recurrent IDH-mutant High-Grade Glioma..:

Ducray, F ; Sanson, M ; Chinot, O...
Neuro-Oncology.  23 (2021)  Supplement_2 - p. ii4-ii4 , 2021
 
?
8

P14.04 Detection of circulating tumor cells in cerebrospina..:

Darlix, A ; Pouderoux, S ; Thezenas, S...
Neuro-Oncology.  23 (2021)  Supplement_2 - p. ii38-ii39 , 2021
 
?
9

P04.02 Postponing the medical treatment is possible in sele..:

Darlix, A ; Rigau, V ; Fraisse, J...
Neuro-Oncology.  21 (2019)  Supplement_3 - p. iii28-iii29 , 2019
 
?
10

P04.14 Loss of oligodendroglial features at recurrence in f..:

Darlix, A ; Duffau, H ; Rigau, V.
Neuro-Oncology.  21 (2019)  Supplement_3 - p. iii31-iii32 , 2019
 
?
12

P01.034Prospective evaluation of alternative therapies in g..:

Le Rhun, E ; Lebrun Frenay, C ; Devos, P...
Neuro-Oncology.  20 (2018)  suppl_3 - p. iii236-iii236 , 2018
 
1-15